ONO-2952: Clinical Trials

5 trials of ONO-2952, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 1, Terminated 1

Follow ONO-2952: new trials by email Literature Review of ONO-2952 trials Research Report on ONO-2952

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
ONO-2952, Placebo comparator - Irritable Bowel Syndrome (IBS)
Phase 2TerminatedOno Pharma USA Inc392013-06-012016-02-25
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
ONO-2952, ONO-2952 Matching Placebo - Irritable Bowel Syndrome (IBS)
Phase 2CompletedOno Pharma USA Inc2002013-04-012016-04-15
ONO-2952 Single-dose PET Study in Healthy Adult Subjects
ONO-2952 - Healthy Adult Subjects
Phase 1CompletedOno Pharma USA Inc162012-08-012013-06-03
Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects
ONO-2952, ONO-2952 Matching Placebo - Healthy
Phase 1CompletedOno Pharma USA Inc362011-12-012012-08-01
Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects
ONO-2952, Placebo - Healthy Adult Subjects
Phase 1CompletedOno Pharma USA Inc482011-05-012012-06-13

Conditions studied

Irritable Bowel Syndrome (2)

Sponsors

Ono Pharma USA Inc (5)

Countries

United States (5)

Results publications

PMID 26249232, PMID 27910150